The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function

Clinical trial NCT00973557 · COMPLETED

Trial details

NCT number: NCT00973557
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Colorectal Cancer Lung Cancer Breast Cancer Glioblastoma

Start date: 2009-09-01
Primary completion: 2011-09-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.